Barbara Krebs

Title: Barbara Krebs: Innovator in Human Antibody Research

Introduction

Barbara Krebs is a notable inventor based in Bergisch Gladbach, Germany. She has made significant contributions to the field of biotechnology, particularly in the development of human antibodies. With a total of 3 patents to her name, her work has the potential to impact various medical conditions.

Latest Patents

Krebs' latest patents focus on Human TIMP-1 antibodies. These human antibodies bind to TIMP-1 and can be utilized as reagents for diagnosing and treating disorders where TIMP-1 levels are elevated. Such disorders include liver fibrosis, alcoholic liver disease, cardiac fibrosis, acute coronary syndrome, lupus nephritis, glomerulosclerotic renal disease, benign prostate hypertrophy, colon cancer, lung cancer, and idiopathic pulmonary fibrosis. The implications of her research are vast, offering new avenues for treatment and diagnosis.

Career Highlights

Throughout her career, Barbara Krebs has worked with prominent organizations, including Bayer Healthcare LLC and Bayer Corporation. Her experience in these companies has allowed her to refine her skills and contribute to groundbreaking research in the field of human antibodies.

Collaborations

Krebs has collaborated with notable colleagues such as Clark Qun Pan and Andreas Knorr. These partnerships have further enhanced her research and development efforts.

Conclusion

Barbara Krebs stands out as an influential inventor in the realm of human antibody research. Her innovative work continues to pave the way for advancements in medical diagnostics and treatments.